Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic Site License Commercial Opportunities in RNA Interference: The Emerging Revolution Drug and Market Development Publishing, July 2003, Pages: 177   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   It is forecasted that the RNAi market will reach $185 million by 2008! Considered the greatest molecular biology innovation of the last decade or two, RNA Interference (RNAi) has become a recognized functional genomics research tool for mammalian gene knock-down studies, target discovery, and validation and shows great therapeutic potential. The vast use for RNAi technology has motivated biotechnology and pharmaceutical companies, entrepreneurs, and venture capitalists to invest in the development and use of this technology. The market for RNAi is already expected to reach $38 million by the year's end. This Commercial Opportunities in RNA Interference Market Analysis Report provides a thorough review of this promising technology. This Report will help you: 1. Pinpoint the market potential of RNAi with an examination of projected market impact through 2008. 2. Discover the competitive advantage of RNAi over comparable technologies, such as antisense, ribozymes, peptide nucleic acids, and morpholinos from a comprehensive review of the capabilities and limitations of both. 3. Identify commercial opportunities for utilizing related technologies to fully implement RNAi, including protein and phenotype profiling, through an assessment of their abilities. 4. Look inside the key RNAi industry players developing siRNA therapeutics, using siRna-mediated target validation, and specializing in siRNA and related reagents via detailed company profiles. 5. Learn about the patenting of RNAi with coverage of current patents and their holders. 6. Get an up-to-date technical review of RNAi through an evaluation of the latest developments, therapeutic breakthroughs, and uses of RNAi technologies. Customers who bought this item also bought RNAi: Broad Application, Expansive Opportunity, 2nd Edition The Prepaid Cards Revolution Molecular Diagnostics - Revolution or Hype The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics Gene Silencing With RNA Interference: A New Generation of Pharmaceuticals Systems Biology - Key to Unlocking the Value within the Omics Revolution The Telecoms Trading Revolution The Future of Digital Entertainment: The Revolution of Personal and Home Technologies in Europe and the US

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster